Showing results (11-20 of 66) with videos related to
Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|August 16, 2025
Beyond traditional endpoints: A multi-state modelling approach to integrating morbidity and mortality in cancer treatments evaluationDouwe Postmus, Jan J Cornelissen, Jan Bogaerts, et al.European Journal of Cancer (Oxford, England : 1990)|April 15, 2014
The components of progression as explanatory variables for overall survival in the Response Evaluation Criteria in Solid Tumours 1.1 databaseSaskia Litière, Elisabeth G E de Vries, Lesley Seymour, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 12, 2014
Evaluation of alternate categorical tumor metrics and cut points for response categorization using the RECIST 1.1 data warehouseSumithra J Mandrekar, Ming-Wen An, Jeffrey Meyers, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 28, 2015
Clinical Utility of Metrics Based on Tumor Measurements in Phase II Trials to Predict Overall Survival Outcomes in Phase III Trials by Using Resampling MethodsMing-Wen An, Yu Han, Jeffrey P Meyers, et al.European Journal of Cancer (Oxford, England : 1990)|November 19, 2013
The role of response evaluation criteria in solid tumour in anticancer treatment evaluation: results of a survey in the oncology communityYan Liu, Saskia Litière, Elisabeth Ge de Vries, et al.European Journal of Cancer (Oxford, England : 1990)|September 3, 2024
Kidney function assessment for eligibility in clinical cancer trials - Data from the European Organisation for Research and Treatment of CancerHannah C Puhr, Eleni Xenophontos, Anne Giraut, et al.Critical Reviews in Oncology/Hematology|November 23, 2006
A joined analysis of two European Organization for the Research and Treatment of Cancer (EORTC) studies to evaluate the role of pegylated liposomal doxorubicin (Caelyx) in the treatment of elderly patients with metastatic breast cancerLaura Biganzoli, Robert Coleman, Alessandro Minisini, et al.Journal of the National Cancer Institute|August 23, 2015
Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall SurvivalMing-Wen An, Xinxin Dong, Jeffrey Meyers, et al.European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 3, 2017
A population-based approach to compare patient-reported outcomes of long-term Hodgkin's lymphoma survivors according to trial participation: a joint study from the Patient-Reported Outcomes Following Initial Treatment and Long-term Evaluation of Survivorship registry and European Organisation for Research and Treatment of CancerMelissa S Y Thong, Michal Kicinski, Corneel Coens, et al.Trials|April 9, 2025
Core outcome sets in cancer clinical trials: current status and future opportunities-an EORTC perspectiveAilbhe Lawlor, Steven MacLennan, Jan Bogaerts, et al.Pageof 7